Optimal Prescribing of Statins to Reduce Cardiovascular Disease

Am J Med. 2023 Dec;136(12):1133-1135. doi: 10.1016/j.amjmed.2023.06.030. Epub 2023 Aug 10.

Authors

David S Schade¹, Teodor Duro², R Philip Eaton²

Affiliations

¹ Department of Internal Medicine, Division of Endocrinology, University of New Mexico Health Sciences Center, Albuquerque. Electronic address: dschade@salud.unm.edu.
² Department of Internal Medicine, Division of Endocrinology, University of New Mexico Health Sciences Center, Albuquerque.

PMID: 37572739
DOI: 10.1016/j.amjmed.2023.06.030

No abstract available

Publication types

Editorial

MeSH terms

Cardiovascular Diseases* / prevention & control
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
Practice Patterns, Physicians'
Risk Factors

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors